Accelerate Your
Business Growth
Grow Your Recurring Revenue Fast Without Giving Up Control
- Preserve equity as we provide debt customized to your business
- Retain control of your board seats and retain your say in how you run your business
- Maximize your flexibility with no financial covenants
- From a maxiumum of $5,000,000 to $15,000,000 in growth capital
- Simple terms. Simple documentation. Simple execution.
Helping Grow Companies
- SaaSSaaS Financing
- TSTech Services
- TTelecom
- DCData Centers
- ISPRural Internet Service Providers
- IoTInternet of Things
- PaaSPlatform as a Service
- DMDigital Media
- SaaSSaaS Financing
- TSTech Services
- TTelecom
- DCData Centers
- ISPRural Internet Service Providers
- IoTInternet of Things
- PaaSPlatform as a Service
- DMDigital Media
- SaaSSaaS Financing
- DCData Centers
- DMDigital Media
- TTelecom
- PaaSPlatform as a Service
- ISPRural Internet Service Providers
- TSTech Services
- IoTInternet of Things
How To Use the Extra Growth Capital
-
Sales and Marketing
-
Development Software
-
Equipment
-
Product Development
-
Aquisition Capital
Simple Qualifications
Annualized recurring revenue in excess of $100,000 per month
Higher Gross Profit (typically in excess of 50%)
Proven business model entering growth mode
Good cash flow in maintenance or low growth mode
Quantifiable SaaS Metrics
Product-Market Fit
Simple Qualifications
Annualized recurring revenue in excess of $100,000 per month
Higher Gross Profit (typically in excess of 50%)
Proven business model entering growth mode
Good cash flow in maintenance or low growth mode
Quantifiable SaaS Metrics
Product-Market Fit
Compare RevTek With Other Funding Sources
BANKS
Banks Won't lend to early stage companies
Not enough
Collateral
Not enough Cash Flow
Not enough Profit
Can't get the deal approved internally
VENTURE CAPITAL
Very Expensive / Highly Dilutive
Founders lose control of Business
Give up Board Seats
40% + IRR expectations
4-6 months to close funding
Lowest cost of capital available
Founders keep control
Revenue is collateral
Founders keep board seats
Revenue is cash
Affordable monthly payments
Profit not necessary
Close within 4 weeks
NOT months
REVTEK Capital provides the lowest cost, quickest solution funding early stage emerging growth companies with recurring revenue
What do REVTEK Portfolio customers have in common?
- Predictable Recurring Revenue with minimal customer attrition
- Product or service that is price inelastic
- High gross profit typically in excess of 50%
- Low fixed expenses
- Early stage emerging growth
Funded 30+ Growing Technology Entrepreneurs
As an intermediary, I have had the opportunity of working with the Principals regarding the financing needs of operating companies which I represent. They are very proficient at, being able to "Peel the Onion Back" in analyzing a particular financing need to come up with solutions that would meet the needs of my clients seeking financing. With it being a flat organization, you are always talking directly with the decision makers who are very responsive in their communication of: How to get to a deal or we do not see this fitting into our lending model.
Thunderbird Corporate Finance, LLC
RevTek Capital has evolved into more than a financial partner for our company. While their financial acumen is evident early on, the long term benefit RevTek Capital offers is the ability to dig into the operations side of your business and offer a fresh perspective or a new connection that can further your business. If you're getting started and want a big value add to your financing, RevTek Capital is an excellent choice.
Apartment Guardian
-
WISPer Ventures / REVTEK Capital went to bat for us early on and has proven to be a great financial partner throughout our record historical growth. They went the extra mile to really understand our business early on, when other lenders simply wouldn’t.
In addition, they have proven to be much more than a direct financing source by helping us raise additional capital from outside sources to further accelerate our growth.
If you are an early stage company seeking growth capital with an objective to minimize dilution, WISPer/REVTEK is the perfect choice.
Nanotherapeutics
-
